891
Views
10
CrossRef citations to date
0
Altmetric
Mini Review

The neurodegeneration in Alzheimer disease and the prion protein

, , &
Pages 60-65 | Received 15 Oct 2012, Accepted 14 Dec 2012, Published online: 01 Jan 2013

Figures & data

Figure 1. Action of anti-PrP antibody (6D11) on the effects of Aβ oligomers. (A) Object recognition test. two concentrations of 6D11 (0.08 and 0.25 µg) were administered 10 min before the ICV injection of vehicle (VEH) or Aβ oligomers (1µM). The effect of Aβ oligomers was similar in the presence or absence of anti-PrP antibody. (B) Viability of murine hippocampal cell cultures exposed for 48 h to Aβ oligomers (1 µM) with vehicle or 6D11 at 0.25, 0.50 and 2 µg/mL. The presence of PrP antibody did not interfere with the Aβ oligomers toxicity. *p < 0.01 vs respective vehicle (Tukey’s test) for methodological details see Balducci et al.Citation41

Figure 1. Action of anti-PrP antibody (6D11) on the effects of Aβ oligomers. (A) Object recognition test. two concentrations of 6D11 (0.08 and 0.25 µg) were administered 10 min before the ICV injection of vehicle (VEH) or Aβ oligomers (1µM). The effect of Aβ oligomers was similar in the presence or absence of anti-PrP antibody. (B) Viability of murine hippocampal cell cultures exposed for 48 h to Aβ oligomers (1 µM) with vehicle or 6D11 at 0.25, 0.50 and 2 µg/mL. The presence of PrP antibody did not interfere with the Aβ oligomers toxicity. *p < 0.01 vs respective vehicle (Tukey’s test) for methodological details see Balducci et al.Citation41

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.